C4 Therapeutics (CCCC)
NASDAQ:CCCC
US Market
Holding CCCC?
Track your performance easily

C4 Therapeutics (CCCC) Financial Statements

440 Followers

C4 Therapeutics Financial Overview

C4 Therapeutics's market cap is currently ―. The company's EPS TTM is $-1.704; its P/E ratio is -3.29; C4 Therapeutics is scheduled to report earnings on February 20, 2025, and the estimated EPS forecast is $-0.46. See an overview of income statement, balance sheet, and cash flow financials.
Sep 24Jun 24Mar 24Dec 23Sep 23
Income Statement-
Total Revenue$ 15.36M$ 12.01M$ 3.04M$ 3.26M$ 11.07M
Gross Profit$ 15.36M$ 12.01M$ 3.04M$ 3.26M$ 11.07M
EBIT$ -24.67M$ -17.72M$ -28.61M-$ -26.03M
EBITDA$ -22.61M$ -14.41M$ -27.85M--
Net Income Common Stockholders$ -24.67M$ -17.78M$ -28.36M$ -34.75M$ -26.15M
Balance Sheet-
Cash, Cash Equivalents and Short-Term Investments$ 255.64M$ 264.10M$ 258.19M$ 253.68M$ 216.57M
Total Assets$ 376.06M$ 381.09M$ 398.37M$ 376.45M$ 333.01M
Total Debt$ 67.09M$ 68.42M$ 69.72M$ 70.98M$ 72.18M
Net Debt$ -188.55M$ -195.68M$ -188.47M$ -182.71M$ -144.39M
Total Liabilities$ 133.40M$ 134.03M$ 140.09M$ 130.34M$ 116.99M
Stockholders Equity$ 242.66M$ 247.02M$ 258.28M$ 246.11M$ 216.02M
Cash Flow-
Free Cash Flow$ -24.12M$ -5.17M$ -18.12M--
Operating Cash Flow$ -24.13M$ -4.97M$ -18.12M$ -24.01M$ -30.71M
Investing Cash Flow$ 162.00K$ -11.71M$ -53.40M$ 31.95M$ 57.73M
Financing Cash Flow$ 10.51M$ 135.00K$ 34.58M$ 57.67M$ -10.75M
Currency in USD

C4 Therapeutics Earnings and Revenue History

C4 Therapeutics Debt to Assets

C4 Therapeutics Cash Flow

C4 Therapeutics Forecast EPS vs Actual EPS

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis